Get the latest NAV of Mirae Asset Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹42.18
▲0.2%1D
NAV as on 27 Jun 2025
22.52%/per year
Since Inception
▲▼
3017 people have invested ₹ 2.1Cr in Mirae Asset Healthcare Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (27-Jun-25)
The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
Powered by IND quant engine
IND ranking is not available for this fund.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (14-Jun-25)
Fund Distribution
as on (14-Jun-25)
Equity 99.4%
Debt & Cash 0.6%
See fund sector allocation details as on (14-Jun-25)
Sector Allocation
Equity 99.4%
Debt & Cash 0.6%
Top 2 Sectors in May were Health, Basic Materials
Health
99%
Basic Materials
1%
Health
99%
Basic Materials
1%
as on (31-May-25)
Equity
Debt & Cash
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 0.5% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹2691 Cr |
Inception Date | 2 June, 2018 |
Min Lumpsum/SIP | ₹5000/₹99 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 18.15% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
Mirae Asset Healthcare Fund Direct Growth is an equity fund. This fund was started on 2 June, 2018. The fund is managed by Vrijesh Kasera. The fund could potentially beat inflation in the long-run.
Mirae Asset Healthcare Fund Direct Growth has given a CAGR return of 22.52% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 18.69%, 25.23% and 23.49% respectively.
Mirae Asset Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Aurobindo Pharma Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 99.00. Mirae Asset Healthcare Fund Direct Growth has no lock in period.
Fund Manager of Mirae Asset Healthcare Fund Direct Growth, since 2 July 2018
3Y CAGR
▲ 50.71
5Y CAGR
▲ 30.95
Mirae Asset Healthcare Fund
VS
Nippon India Pharma Fund Direct Growth